comparemela.com

Latest Breaking News On - Trophic communications - Page 7 : comparemela.com

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising t

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)LYON, France (BUSINESS WIRE) $MAAT Regulatory News:MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therap.

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer

Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Osivax Appoints Dr Nicola Groth as Chief Medical Officer

Osivax Appoints Dr Nicola Groth as Chief Medical Officer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.